The impact of mast cell responses to IFN on the therapeutic function of IFN or on the development of side effects at mast cell rich sites, such as local inflammatory responses and sterile abscesses at IFN skin injection sites clinically remains to be determined. The gene discussed is IFNA1; the disease is abscess.